Tissue engineering of stratified articular cartilage from chondrocyte subpopulations  by Klein, T.J. et al.
Tissue engineering of stratified articular cartilage from chondrocyte
subpopulations
T. J. Klein M.S.†, B. L. Schumacher B.S.†, T. A. Schmidt M.S.†, K. W. Li Ph.D.†, M. S. Voegtline
Ph.D.†, K. Masuda M.D.‡§, E. J.-M. A. Thonar Ph.D.‡§i and R. L. Sah M.D., Sc.D.†¶††*
†Department of Bioengineering, University of California-San Diego, La Jolla, CA, USA
‡Department of Biochemistry, Rush Medical College, Chicago, IL, USA
§Department of Orthopedic Surgery, University of California-San Diego, La Jolla, CA, USA
iDepartment of Internal Medicine, Rush Medical College, Chicago, IL, USA
¶Department of Orthopedic Surgery, Rush Medical College, Chicago, IL, USA
††Whitaker Institute of Biomedical Engineering, University of California-San Diego, La Jolla, CA, USA
Summary
Objective: To test if subpopulations of chondrocytes from different cartilage zones could be used to engineer cartilage constructs with
features of normal stratification.
Design: Chondrocytes from the superficial and middle zones of immature bovine cartilage were cultured in alginate, released, and seeded
either separately or sequentially to form cartilage constructs. Constructs were cultured for 1 or 2 weeks and were assessed for growth,
compressive properties, and deposition, and localization of matrix molecules and superficial zone protein (SZP).
Results: The cartilaginous constructs formed from superficial zone chondrocytes exhibited less matrix growth and lower compressive
properties than constructs from middle zone chondrocytes, with the stratified superficial-middle constructs exhibiting intermediate properties.
Expression of SZP was highest at the construct surfaces, with the localization of SZP in superficial-middle constructs being concentrated at
the superficial surface.
Conclusions: Manipulation of subpopulations of chondrocytes can be useful in engineering cartilage tissue with a biomimetic approach, and
in fabricating constructs that exhibit stratified features of normal articular cartilage.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
Articular cartilage normally functions as the low-friction,
wear-resistant, load-bearing tissue at the ends of bones in
synovial joints. Unfortunately, articular cartilage becomes
degenerate frequently and increasingly with age, and has
minimal capacity for self-repair1. To address this problem,
tissue engineering approaches to repair cartilage defects
are under active investigation. Clinical therapies currently
range from transplanting osteochondral allografts with
mature articular cartilage2 to isolating autogeneic chondro-
cytes from a biopsy of cartilage, proliferating these cells in
culture, and then injecting them into the defect site under a
periosteal patch3. Recent efforts have focused on fabricat-
ing cartilaginous tissue in vitro with the view that such
constructs could circumvent the lack of donor supply for
allografts, be implanted with a simpler surgical procedure,
and allow more rapid patient remobilization4,5. A common
design goal for such constructs is to form tissue with
properties similar to those of immature articular cartilage,
which has a capacity to repair6. The alginate-recovered-
chondrocyte method recapitulates certain features of im-
mature cartilage, including a high cell density in a tissue
free of exogenous scaffolds, by first culturing cells in a
three-dimensional gel to generate a pericellular matrix,
then releasing these cells and their newly formed matrix
from the gel, and seeding them on cell culture inserts at a
high density7.
The cell phenotype and matrix properties of articular
cartilage normally vary with depth from the articular
surface. This stratification confers specialized functional
properties to the superficial, middle, and deep zones of
cartilage8. The superficial zone has relatively low sulfated-
glycosaminoglycan (GAG) and aggrecan content8 with a
correspondingly low compressive modulus9, allowing the
superficial zone to conform to the opposing tissue surface
and thereby distribute stress under compressive load. In
contrast, collagen content is similar among the zones8.
Differences in the phenotype of chondrocytes, the cells
within articular cartilage, appear to be responsible primarily
for these variations. The chondrocytes of the superficial
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zone secrete GAG at a relatively low rate10–12. Conversely,
chondrocytes of the superficial zone secrete superficial
zone protein (SZP) at a high rate, and biosynthesis of SZP
by articular chondrocytes has been used to define this
population of cells and also demarcate the superficial zone
of cartilage13–15. SZP appears to have important mechan-
ical properties, being identical or closely related to a
molecule termed lubricin16 and imparting lubrication prop-
erties to the articular surface17–19. The superficial zone of
cartilage also appears to be typically the region damaged
first, during age-associated weakening and the early
stages of osteoarthritis6.
Despite the marked zonal variations in cartilage biology
and function, and the importance of the superficial zone,
few attempts have been made previously to fabricate
articular cartilage tissue with stratification. Previous studies
have focused on the differences between chondrocytes in
the deeper regions of cartilage20. The objectives of this
study were to determine if subpopulations of chondrocytes
from the superficial or middle zones (1) would differentially
express SZP, collagen, GAG, and compressive properties
in engineered cartilage tissue, and (2) could be used to
fabricate cartilage constructs with normal physiological
stratification, including differential expression of SZP.
Materials and methods
CARTILAGE HARVEST, CHONDROCYTE ISOLATION AND CULTURE,
AND CONSTRUCT FORMATION
Osteochondral blocks were harvested from the patello-
femoral groove of bovine calf knees using a scalpel. The
blocks were from six animals, 1–3 weeks old, with the
blocks from each animal treated separately. Blocks were
then mounted on a sledge microtome and sectioned in
0.2 mm slices from the articular surface. Slices were pooled
from the superficial (0–0.2 mm) and middle (0.4–1.6 mm)
zones. Superficial and middle zone chondrocyte sub-
populations were isolated by sequential digestion for 1 h
with 0.2% pronase (Sigma–Aldrich, St. Louis, MO) and
12 h with 0.025% collagenase P (Roche Diagnostics,
Indianapolis, IN)21. Chondrocytes were washed and resus-
pended in 1.2% alginate (Keltone LV, Kelco, Chicago, IL) in
150 mM NaCl at 4 million cells/ml, and then expressed from
a 22-gage needle into a 102 mM CaCl2 solution to polym-
erize the alginate as small beads (∼2.7 mm in diameter)
thus entrapping the chondrocytes22. The alginate beads
were then transferred to T-175 flasks containing DMEM/
F12 with additives (10% fetal bovine serum, 25 µg/ml
ascorbic acid, 100 U/ml penicillin, 100 µg/ml streptomycin,
0.25 µg/ml Fungizone, 0.1 mM MEM non-essential amino
acids, 0.4 mM L-proline, 2 mM L-glutamine) and cultured for
7 days with daily medium changes (1 ml per million cells).
Cells and their associated matrix (CM) were released from
alginate using 55 mM sodium citrate in 150 mM NaCl.
Selected cells were labeled by incubating for 2 h in medium
containing 10 µM CellTracker™ Orange CMTMR (middle)
or Green CMFDA (superficial) (Molecular Probes, Eugene,
OR). CM were then seeded onto 6.5 or 12 mm diameter
cell inserts with a 0.4 µm pore size polyester membrane
(Corning Inc., Corning, NY) to achieve a final density of
5 million cells per cm2 membrane area.
Three types of cartilage constructs were formed: homo-
geneous superficial (S), homogeneous middle (M), and
stratified with superficial layered atop middle (S/M) (Fig. 1).
S and M constructs were formed by seeding CM at one
time, while S/M constructs were formed by seeding middle
CM (2.5 million/cm2) followed 18 h later by superficial CM.
All groups were incubated overnight, to allow the CM to
coalesce, prior to flooding the tissue culture well with
medium. Constructs were cultured for 1 or 2 weeks with
daily changes of medium (DMEM with additives). At the end
of culture, constructs were removed from the membrane,
measured for thickness with a current sensing micrometer,
and weighed wet. To assess the stability of cell stratifica-
tion, some samples were sectioned after 1 week, and
fluorescence and phase contrast photomicrographs of
sections were overlayed using Adobe Photoshop (Adobe
Systems, San Jose, CA).
BIOCHEMICAL ANALYSIS
Certain constructs (N6–19 constructs per type per time
point) were used for biochemical analyses. A single 3 mm
Fig. 1. Schematic of methods used to engineer cartilage tissue using cells isolated separately from superficial and middle zones of articular
cartilage. Homogeneous constructs were generated from chondrocytes of the superficial (S) or middle (M) zones. Stratified constructs (S/M)
were formed by sequentially seeding different chondrocyte subpopulations, with time allowed between seedings for the initial layer to
coalesce. Superficial (white) and middle (gray) zone chondrocytes and the tissues derived from them are shaded differently to emphasize
their location in culture and in the engineered tissue.
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diameter disk, centered 1.5 mm from the center of the
construct, was punched from each construct. The disks
were then solubilized with proteinase K (Roche Diagnos-
tics), and analyzed for DNA23, for collagen as hydroxy-
proline24 assuming 7.25 g collagen/g hydroxyproline25, and
for GAG26.
MECHANICAL TESTING
Other constructs (N6–10 constructs per type per time
point) were punched to a diameter of 4.8 mm, then trans-
ferred to a radially confining chamber filled with phosphate
buffered saline (PBS) and subjected to compression tests
essentially as described previously27. To increase the
sensitivity of the system, a load cell with 1 mN resolution
(Model 31/1435-03, Sensotec, Columbus, OH) was used.
This allowed determination of the equilibrium confined
compressive modulus, HA0, at a resolution of 0.1 kPa for
the sample geometry and test protocol used.
IMMUNOHISTOCHEMISTRY
A third set of constructs were treated for 16 h with 0.1 µM
monensin (Sigma–Aldrich) in medium to prevent secretion
of SZP from the Golgi apparatus14, frozen in O.C.T. com-
pound (Fisher Scientific Co., Tustin, CA), and cut normal to
the construct surface into 40 µm thick sections. Sections
were probed for SZP and Col II using the Vectastain ABC
Elite Kit (Vector Laboratories, Burlingame, CA) as per
manufacturer’s instructions, employing an anti-bovine SZP
monoclonal antibody (mAb), 3-A-4 (a generous gift from Dr
Bruce Caterson, Wales, UK)14, a mouse mAb anti-Col II
antibody cocktail (Chondrex, Redmond, WA), or mouse IgG
(Vector Labs) as control. Full-thickness bovine articular
cartilage treated with monensin served as a positive (in the
superficial zone) and negative control (in the deeper zones)
for SZP. Bovine cartilage and tendon served as positive
and negative controls for Col II, respectively. Sections were
counterstained with Methyl Green (Vector Labs) for
2–5 min at room temperature and mounted in Crystal
Mount (Biomeda, Foster City, CA). Serial sections were
stained with 0.1% Alcian Blue in 0.4 M MgCl2, 0.025 M
sodium acetate, pH 5.6 to stain GAG11,28. Positive reac-
tivity with SZP and Col II, and GAG staining were docu-
mented by photomicroscopy using brightfield illumination.
SZP positive and negative cells were marked using Adobe
Photoshop and analyzed to determine the percentage of
positive cells as a function of depth from the top and bottom
surfaces, using NIH Image 1.62.
ELISA FOR SZP
Portions of medium from days 12 to 14 of culture (9–13
constructs per type) were analyzed for SZP by ELISA.
Medium was allowed to bind to the wells of 96-well plates
overnight at 4°C in PBS containing 0.1 M guanidine-HCl,
pH 7.4. Conditioned medium from cartilage explants, which
was standardized against purified SZP13,14, was also
assayed in twofold dilutions to generate a sigmoidal stan-
dard curve. Plates were washed extensively with PBS
containing 0.1% Tween-20 (PBS-T) between all steps.
Non-specific binding was blocked with 5% non-fat milk in
PBS for 1 h. Plates were then incubated for 1 h with a
1:1000 dilution of primary mAb 3-A-4 in PBS with 0.1%
bovine serum albumin (Sigma–Aldrich), followed by an
additional 1 h incubation with a 1:1000 dilution of a horse-
radish peroxidase conjugated goat-anti-mouse IgG (Pierce,
Rockford, IL) secondary antibody. ABTS substrate (Roche
Diagnostics, Indianapolis, IN) was applied for 30 min and
the reaction was stopped by the addition of 1% SDS in
water. Optical density measurements were made at 405 nm
on an EMAX microplate reader (Molecular Devices, Menlo
Park, CA). Optical densities at three dilutions were used to
calculate sample SZP concentration using the standard
curve.
WESTERN BLOT FOR SZP
Portions of medium from days 12 to 14 of culture were
pooled from five constructs per experimental condition and
analyzed for SZP by Western Blot. Pooled medium and
purified SZP13,14 were digested with chondroitinase ABC
(Seikagaku America, Rockville, MD) in sample buffer
(0.1 M Tris and 0.05 M sodium acetate, pH 8.0) for 2 h at
37°C. Samples were mixed with an equal volume of 2×
Laemmli sample buffer and boiled for 3 min immediately
prior to electrophoresis on a 5% SDS-polyacrylamide gel.
Separated proteins were transferred to an Immobilon-P
membrane (Millipore, Burlington, MA) overnight at 4°C with
1.4 mA/cm2 in a transfer buffer containing 12 mM Tris,
0.3 mM EDTA, and 6 mM sodium acetate, pH 7.429. The
membrane was then removed and blocked for 30 min with
5% non-fat dry milk in PBS-T. After rinsing, the membrane
was incubated for 1 h with mAb 3-A-4 diluted 1:200 in
PBS-T, followed by incubation with a secondary antibody,
as above, for 2 h. The proteins were visualized with
hyperfilm—ECL (Amersham Pharmacia, Piscataway, NJ).
The approximate molecular weight of the SZP bands was
determined using rainbow molecular weight standards
(Amersham Pharmacia).
STATISTICAL ANALYSIS
Data are expressed as mean±S.E.M. The effects of con-
struct type and culture duration were assessed by two-way
ANOVA (α0.05) and appropriate Tukey post-hoc tests,
with animal treated as a random variable, using Systat
5.2.1 (Systat Software, Inc., Richmond, CA).
Results
CONSTRUCT PHYSICAL PROPERTIES
Cohesive cartilage constructs that could withstand
manual manipulation after removal from the membrane
were fabricated from chondrocytes, isolated separately
from superficial and middle zones of bovine calf cartilage,
using the alginate-recovered-chondrocyte method7 (Fig. 1).
The cells isolated from the superficial and middle zones
were relatively enriched and devoid, respectively, in the
proportion of cells expressing SZP (data not shown). In S/M
constructs, the tissue layers with cells of distinct origin were
created and maintained, as demonstrated by localization of
fluorescent-labeled superficial and middle zone cells (data
not shown). Construct thickness varied with construct type
(P<0.001) and increased with culture duration (P<0.001).
After 1 and 2 weeks of culture, M constructs were signifi-
cantly thicker than S/M constructs, which were in turn
thicker than S constructs [Fig. 2(A)]. The wet weight of
constructs varied in a manner consistent with thickness
data [Fig. 2(B)]. Cell proliferation was also evident, as
DNA content increased from 1 to 2 weeks (P<0.01), but
Osteoarthritis and Cartilage Vol. 11, No. 8 597
was similar for the three types of constructs (P0.12)
[Fig. 2(C)].
CARTILAGE MATRIX DEPOSITION AND LOCALIZATION, AND
COMPRESSIVE PROPERTIES
Cartilage matrix constituents, GAG and collagen, were
deposited at different rates by the various types of con-
structs. GAG content increased 51% from 1 to 2 weeks
(P<0.001) and was significantly greater in M than in S
and S/M constructs [each, P<0.001, Fig. 2(D)]. Collagen
content tripled from 1 to 2 weeks (P<0.001) and was
significantly greater in M than S constructs (P<0.001), and
at an intermediate level in S/M constructs [P<0.001 vs S,
P<0.05 vs M, Fig. 2(E)]. The equilibrium confined compres-
sive modulus tended to increase with time (P0.06), and
was greater in M constructs than in S and in S/M constructs
[P<0.01 and P<0.05, respectively, Fig. 2(F)].
Matrix constituents typical of normal articular cartilage
were detected throughout the engineered constructs. Sul-
fated GAG was visualized throughout the thickness of all
constructs with Alcian Blue dye, using conditions specific
for chondroitin sulfate and keratan sulfate [Fig. 3(A, E, H)].
While GAG was present throughout the thickness of all
sections, Alcian Blue staining of the S/M constructs was
heavier in the bottom portion [Fig. 3(E)]. Collagen type II
(Col II), a marker of hyaline cartilage, was also localized
throughout the thickness of all types of constructs by
immunohistochemistry [Fig. 3(B, F, I)].
SZP IMMUNOLOCALIZATION AND SECRETION
SZP, a molecule that is normally a product of chondro-
cytes in the superficial region of cartilage, was synthesized
variably by S, S/M, and M constructs. In S and S/M
constructs, SZP was immunolocalized within a high pro-
portion of the chondrocytes [Fig. 3(D, G)]. However, in M
constructs SZP was localized within a low proportion of
chondrocytes [Fig. 3(J)]. Cells near the top (free) and
bottom (on the membrane) surfaces of S constructs stained
more frequently than cells of the interior, while cells at the
free surface stained more frequently than other cells in S/M
constructs. After 2 weeks of culture, the percentage of cells
positive for SZP averaged 52% in the top 0.2 mm, and then
dropped to 36% in the next 0.2 mm, and only 13% in the
remainder of the tissue [Fig. 4(A)]. In contrast, S constructs
showed similarly high percentages of SZP-positive cells at
both surfaces (48% in both the top 0.2 mm and the bottom
0.2 mm) and lower percentages in the interior (20% at
0.2–0.4 mm, 29% in the remainder of tissue). M constructs
had a low proportion of SZP-positive cells throughout,
ranging from 2% in the top 0.2 mm to 15% in the bottom
0.2 mm [Fig. 4(A)].
The extent of SZP secretion into the medium varied
between the different constructs. S constructs secreted
21.5±4.0 µg/[cm2 day], a rate approximately 3.4-fold higher
than both S/M and M constructs [P<0.001, Fig. 4(B)]. On
Western blot, the SZP in media pooled from days 12 to 14
of culture had the same electrophoretic mobility as SZP
secreted by chondrocytes in cartilage explants, with an
approximate molecular weight of 345 kD (data not shown).
Discussion
The above results indicate that chondrocyte subpopula-
tions can play an important role in determining the struc-
ture, composition, metabolism, and mechanical function of
tissue-engineered cartilage constructs, and that multiple
chondrocyte populations may be used to form cartilage with
stratification features that are typical of normal articular
cartilage. A variety of cell sources could be used to impart
Fig. 2. Structural, compositional, and functional properties of three types of cartilage constructs formed from superficial and/or middle zone
chondrocytes after 1 and 2 weeks in culture. Wet weight (WW), DNA, GAG, and collagen (Col) were all normalized to the cross-sectional
area of the construct. (F) The equilibrium modulus, HA0, was measured in confined compression. Data are expressed as mean±S.E.M.(P<0.001 (↔), P<0.01 (+), P<0.05 (♦)).
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Fig. 3. Localization of matrix and secreted molecules in S, S/M, and M cartilage constructs cultured for 2 weeks. Some tissue sections (A,
E, H) were stained with Alcian Blue to detect glycosaminoglycan. Other sections were immunostained for (B, F, I) type II collagen or (D, G,
J) SZP, and counterstained with Methyl Green. Positive immunoreactivity is indicated by a purple color. Counterstaining results in a
blue–green color. For clarity, higher power images (D1, G1, J1) of the top and (D2, G2, J2) of the middle of each construct are shown. To show
specificity of immunostaining, high power images (C1, C2) of a section treated with non-specific control IgG are shown. Bar, 100 µm.
Fig. 4. Depth-dependent SZP expression in each construct type after 2 weeks of culture. (A) Cells were counted in 0.2 mm bins, with cells
between 0.4 mm from the top surface and 0.2 mm from the bottom surface combined ({) to allow for variations in construct thickness.
(B) SZP measured in spent medium from days 12 to 14 of construct culture by indirect ELISA, normalized to construct area and culture
duration (P<0.001 (↔)).
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on the engineered tissue the phenotypic zonal character-
istics of articular cartilage, such as lubrication at the sur-
face19, and higher resistance to compression in the deeper
layers9. Like the distinctive superficial and middle zones of
normal articular cartilage30, S constructs, formed from
superficial zone chondrocytes, were different from M con-
structs, formed from middle zone chondrocytes, with the
former having relatively low GAG content and compressive
modulus (Fig. 2). Additionally, like articular cartilage with
normal stratification14, S/M constructs, formed by layering
chondrocytes from the superficial zone atop those from the
middle zone, exhibited expression of SZP by cells within a
few cell layers of the free surface of the tissue, whereas
S and M constructs did not exhibit normal stratification
(Figs. 3 and 4).
The biomimetic approach of engineering cartilage tissue
to have functional stratification may be useful with a variety
of methods of forming cartilaginous tissue in vitro. The
tissue engineering method used here, involving pre-
incubation of chondrocytes within a three-dimensional
gel, facilitates formation of cartilaginous matrix even of
adult chondrocytes31. The method of seeding cells in
biodegradable scaffolds32 could also be modified to form
cartilage layers sequentially and with distinct cell popula-
tions. Important criteria for the cells of each layer of the
construct may include SZP and collagen production in the
superficial layer, and collagen expression in addition to a
greater amount (relative to the superficial layer) of aggre-
can production with little SZP expression in the deeper
layers. Since there is a limited supply of primary chondro-
cytes from different zones, additional expansion of the few
cells or an alternative cell source may be required for
clinical application. Chondrocytes from the superficial zone
can be expanded and maintain expression of SZP in
monolayer culture33. Also, chondrocytes can be expanded
and then induced to redifferentiate by three-dimensional
culture34. Certain synovial cells may be useful as an
alternative source of cells for the superficial layer of carti-
lage constructs, as they also express SZP14. Further, the
individual layers may be composed of heterogeneous cell
populations, rather than a single population.
The degree of in vitro maturation of engineered cartilage
typically varies with the duration of culture. The short-term
in vitro studies, described here, have resulted in stratified
tissue constructs that recapitulate certain features of imma-
ture, fetal-like cartilage tissue, including high cellularity and
a low compressive modulus, while exhibiting SZP stratifi-
cation akin to both immature and mature normal articular
cartilage. While the compressive modulus of the constructs
[4 kPa, Fig. 2(F)] fabricated in this study was ∼20 times
lower than that of the top 1 mm of third trimester fetal
bovine cartilage (80 kPa)35, the compressive modulus of
other constructs become similar to that of even adult
articular cartilage with extended culture duration, and
stimulation with growth factors and bioreactor culture36–38.
Both immature and mature cartilaginous tissue may be
useful for repair of cartilage defects. The degree of con-
struct maturation may affect the therapeutic efficacy of the
engineered cartilage following transplantation. Immature
cartilage, when injured, apparently has the intrinsic ca-
pacity to heal39, whereas adult cartilage does not40 and
integrates poorly with biological grafts41. Engineered carti-
lage with immature mechanical properties also has a
greater integration potential than engineered cartilage
with more fully developed matrix properties42. In addition,
immature cartilage constructs are likely to have a high
growth potential and allow for enhanced filling of a defect
with irregularities. On the other hand, implants with fully
functional articular cartilage, such as osteochondral allo-
grafts, may also be advantageous, and more effectively
and quickly contribute to mechanical load bearing and a
relatively short duration of post-operative rehabilitation.
While formation of stratified cartilaginous tissue was
achieved, refinement of the engineering methodology and
biological understanding is likely to be useful for scientific
and possible clinical applications. More complete charac-
terization of the enriched subpopulations used in this study
and mixed populations used in others could be achieved
using zonal molecular markers such as SZP14 and
clusterin43. Purification of cell subpopulations may allow
generation of cartilage constructs with a greater degree
of stratification and enable more detailed experimental
studies.
The mechanisms of regulation of chondrocyte phenotype
and tissue growth during extended in vitro culture remain to
be fully elucidated. Here, the number and proportion of
cells in S constructs expressing SZP, as judged by immu-
nohistochemistry of the parent population and the grown
construct, declined with culture duration. This could be due
to a relatively rapid proliferation of an initially small popu-
lation of middle zone cells, which would tend to decrease
the apparent population of SZP-positive cells in long term
cultures. Alternately, the pattern of maintenance of SZP
expression by cells near the surfaces of S constructs could
suggest a phenotypic dependence on nutrient levels or
chemical gradients in the tissue, possibly like those estab-
lished in vivo due to the avascular nature of cartilage.
Additionally, SZP expression could be regulated by cell–cell
or cell–matrix interactions.
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